Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · IEX Real-Time Price · USD
7.85
+0.15 (1.95%)
At close: Mar 28, 2024, 4:00 PM
7.69
-0.16 (-2.04%)
After-hours: Mar 28, 2024, 5:00 PM EDT

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
387339308496--
Market Cap Growth
-10.05%-37.90%---
Enterprise Value
181132140348-17-32
PE Ratio
-4.44-4.44-5.24-10.74--
PB Ratio
1.721.501.583.26--
P/FCF Ratio
-5.25-5.25-5.53-14.36--
P/OCF Ratio
-5.31-5.31-5.64-15.30--
EV/EBITDA Ratio
-1.81-1.81-2.47-7.670.811.37
EV/EBIT Ratio
-1.74-1.74-2.38-7.530.781.34
EV/FCF Ratio
-2.05-2.05-2.51-10.070.691.42
Debt / Equity Ratio
0.090.090.110.01-0.00
Debt / EBITDA Ratio
-0.27-0.27-0.37-0.02-0.00
Debt / FCF Ratio
-0.30-0.30-0.37-0.03-0.00
Quick Ratio
18.3018.3018.0620.276.545.28
Current Ratio
18.7618.7618.8120.906.945.42
Interest Coverage
------4839.00
Return on Equity (ROE)
-42.20%-42.20%-40.50%-211.90%30.70%-
Return on Assets (ROA)
-36.70%-36.70%-36.20%-50.70%-101.90%-
Return on Capital (ROIC)
-34.63%-34.63%-27.86%-23.00%20.43%27.63%
Earnings Yield
-19.72%-22.54%-19.08%-9.31%--
FCF Yield
-16.66%-19.04%-18.08%-6.96%--
Buyback Yield / Dilution
-32.34%-32.34%-480.18%-1305.21%92.08%-
Total Shareholder Return
-32.34%-32.34%-480.18%-1305.21%92.08%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).